0009-0001-8749-7990 About
My current research focuses on understanding of molecular mechanisms how environmental neurotoxicant and manganese overexposure induces Parkinson's like neurological disease, particularly in developmentally sensitive early-life periods, and generate a treatment for this disease.
Employment
-
The University of Texas at Austin Postdoctoral Associate
-
The University of Texas at Austin Postdoctoral fellow
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (13)
- NR4A1 is a HIF-dependent repressor of SLC30A10 transcription that controls manganese homeostasis Save
- A ‘brain-first’ mouse model of progressive alpha-synuclein pathology via intranasal rotenone administration Save
- Elevated brain manganese induces motor disease by upregulating the kynurenine pathway of tryptophan metabolism Save
- Chronic DSS-Induced Colitis Exacerbates Parkinson’s Disease Phenotype and Its Pathological Features Following Intragastric Rotenone Exposure Save
- Association of COVID-19 with Comorbidities: An Update Save
- Intranasal Rotenone Induces Alpha-Synuclein Accumulation, Neuroinflammation and Dopaminergic Neurodegeneration in Middle-Aged Mice Save
- Neuroprotective Effect of Swertiamarin in a Rotenone Model of Parkinson’s Disease: Role of Neuroinflammation and Alpha-Synuclein Accumulation Save
- AMPK-dependent autophagy activation and alpha-Synuclein clearance: a putative mechanism behind alpha-mangostin’s neuroprotection in a rotenone-induced mouse model of Parkinson’s disease Save
- Chlorogenic Acid: a Polyphenol from Coffee Rendered Neuroprotection Against Rotenone-Induced Parkinson’s Disease by GLP-1 Secretion Save
- Intranasal Exposure to Low-Dose Rotenone Induced Alpha-Synuclein Accumulation and Parkinson’s Like Symptoms Without Loss of Dopaminergic Neurons Save